These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29643007)

  • 21. Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Hastings A; Cullinane P; Wrigley S; Revesz T; Morris HR; Dickson JC; Jaunmuktane Z; Warner TT; De Pablo-Fernández E
    Neurology; 2024 Jun; 102(11):e209453. PubMed ID: 38759132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
    Paviour DC; Price SL; Stevens JM; Lees AJ; Fox NC
    Neurology; 2005 Feb; 64(4):675-9. PubMed ID: 15728291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
    Massey LA; Micallef C; Paviour DC; O'Sullivan SS; Ling H; Williams DR; Kallis C; Holton JL; Revesz T; Burn DJ; Yousry T; Lees AJ; Fox NC; Jäger HR
    Mov Disord; 2012 Dec; 27(14):1754-62. PubMed ID: 22488922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.
    Righini A; Antonini A; De Notaris R; Bianchini E; Meucci N; Sacilotto G; Canesi M; De Gaspari D; Triulzi F; Pezzoli G
    AJNR Am J Neuroradiol; 2004; 25(6):927-32. PubMed ID: 15205125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus.
    Virhammar J; Blohmé H; Nyholm D; Georgiopoulos C; Fällmar D
    J Neuroimaging; 2022 Jan; 32(1):90-96. PubMed ID: 34520581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
    Bae YJ; Kim JM; Kim E; Lee KM; Kang SY; Park HS; Kim KJ; Kim YE; Oh ES; Yun JY; Kim JS; Jeong HJ; Jeon B; Kim SE
    Mov Disord; 2016 May; 31(5):684-92. PubMed ID: 26990970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of MSA-P and PSP-P in Early Stage].
    Yamawaki T
    Brain Nerve; 2020 Apr; 72(4):331-343. PubMed ID: 32284458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic Uncertainty.
    Chougar L; Faucher A; Faouzi J; Lejeune FX; Gama Lobo G; Jovanovic C; Cormier F; Dupont G; Vidailhet M; Corvol JC; Colliot O; Lehéricy S; Grabli D; Degos B
    Mov Disord; 2024 May; 39(5):825-835. PubMed ID: 38486423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphometry MRI in the differential diagnosis of parkinsonian syndromes.
    Gama RL; Távora DF; Bomfim RC; Silva CE; Bruin VM; Bruin PF
    Arq Neuropsiquiatr; 2010 Jun; 68(3):333-8. PubMed ID: 20602031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
    Reiter E; Mueller C; Pinter B; Krismer F; Scherfler C; Esterhammer R; Kremser C; Schocke M; Wenning GK; Poewe W; Seppi K
    Mov Disord; 2015 Jul; 30(8):1068-76. PubMed ID: 25773707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.